Gisele Dion
Director/Board Member chez CYTEK BIOSCIENCES, INC.
Fortune : 33 550 $ au 31/03/2024
Profil
Gisele Dion is currently the Director at Inhibikase Therapeutics, Inc. and an Independent Director at Cytek Biosciences, Inc. She previously worked as the Senior Director-Technical Accounting & Controller at Biogen, Inc. from 2007 to 2016, and as the Chief Accounting Officer at Shire Plc from 2017 to 2019.
She also served as the Chief Accounting Officer, Senior VP & Controller at Takeda Pharmaceutical Co., Ltd.
from 2019 to 2021, and at Shire Pharmaceuticals LLC from 2016 to 2019.
Ms. Dion received her undergraduate degree from Fairfield University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CYTEK BIOSCIENCES, INC.
0,00% | 14/06/2023 | 5 000 ( 0,00% ) | 33 550 $ | 31/03/2024 |
| 01/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Gisele Dion
| Sociétés | Poste | Début |
|---|---|---|
| CYTEK BIOSCIENCES, INC. | Director/Board Member | 01/03/2021 |
| INHIBIKASE THERAPEUTICS, INC. | Director/Board Member | 01/09/2022 |
Anciens postes connus de Gisele Dion
| Sociétés | Poste | Fin |
|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Comptroller/Controller/Auditor | 01/03/2021 |
| SHIRE | Comptroller/Controller/Auditor | 01/01/2019 |
Shire Pharmaceuticals LLC
 Shire Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals LLC is an American company that manufactures pharmaceutical products. | Comptroller/Controller/Auditor | 01/01/2019 |
| BIOGEN INC. | Comptroller/Controller/Auditor | 01/01/2016 |
Formation de Gisele Dion
| Fairfield University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BIOGEN INC. | Health Technology |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| CYTEK BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
| Inhibikase Therapeutics, Inc. | |
Shire Pharmaceuticals LLC
Shire Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals LLC is an American company that manufactures pharmaceutical products. | Health Technology |
